Phase-II trial with vindesine for regression induction in patients with leukemias and hematosarcomas
- 1 December 1979
- journal article
- research article
- Published by Springer Nature in Cancer Chemotherapy and Pharmacology
- Vol. 2 (4) , 247-255
- https://doi.org/10.1007/bf00257189
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- ANTI-TUMOR ACTIVITY OF DEACETYL VINBLASTINE AMIDE SULFATE (VINDESINE) IN RODENTS AND MITOTIC ACCUMULATION STUDIES IN CULTURE1978
- PHASE-II CLINICAL-TRIAL WITH VINDESINE FOR REMISSION INDUCTION IN ACUTE-LEUKEMIA, BLASTIC CRISIS OF CHRONIC MYELOID-LEUKEMIA, LYMPHOSARCOMA, AND HODGKINS-DISEASE - ABSENCE OF CROSS-RESISTANCE WITH VINCRISTINE1978
- Structure-activity relationships of dimeric Catharanthus alkaloids. 1. Deacetyl vinblastine amide (vindesine) sulfateJournal of Medicinal Chemistry, 1978
- A phase II clinical trial of peptichemio. Clinical screening cooperative group of European Organisation on Research on Treatment of Cancer (E.O.R.T.C).1977
- ACTION OF VINCA ALKALOIDS VINCRISTINE, VINBLASTINE, AND DESACETYL VINBLASTINE AMIDE ON AXONAL FIBRILLAR ORGANELLES INVITRO1977
- Toxicology of vindesine (desacetyl vinblastine amide) in mice, rats, and dogsJournal of Toxicology and Environmental Health, 1976
- Cancer chemotherapy: its role in the treatment strategy of hematologic malignancies and solid tumors.1976